40 related articles for article (PubMed ID: 24018495)
1. Serum interleukin-10 and alpha-fetoprotein: A combined diagnostic approach for hepatocellular carcinoma in Egyptians with HCV.
Sharafeldin MA; Suef RA; Mousa AA; Ziadah DH; Farag MMS
Pathol Res Pract; 2024 Jun; 258():155327. PubMed ID: 38692084
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of Circular RNA SMARCA5 as a Novel Biomarker for Hepatocellular Carcinoma.
Bedair HM; El-Banna EA; Ahmed EA; Elhelbawy MG; Abdelfattah A; Khalaf FA; Abdel-Samiee M; El Sharnoby A
Asian Pac J Cancer Prev; 2024 Apr; 25(4):1411-1417. PubMed ID: 38680002
[TBL] [Abstract][Full Text] [Related]
3. Suppressor of Cytokine Signaling-3 Gene Polymorphisms and the Risk of Hepatocellular Carcinoma in Chronic Hepatitis C Patients in Egypt.
El Sharnoby A; Bedair HM; Raia GYS; Hamed N; Sabry A; Khalaf FA; Abd Elhamed MR; Abdel-Samiee M
Asian Pac J Cancer Prev; 2023 Dec; 24(12):4253-4261. PubMed ID: 38156861
[TBL] [Abstract][Full Text] [Related]
4. Altered Protein and Gene Expression of Beclin-1 Correlates with Poor Prognosis of Hcv-Associated Hepatocellular Carcinoma in Egyptian Patients.
Ehsan NA; Mosbeh AM; Elkhadry SW; Gomaa AI; Elsabaawy MM; Elazab DS
Asian Pac J Cancer Prev; 2021 Apr; 22(4):1115-1122. PubMed ID: 33906303
[TBL] [Abstract][Full Text] [Related]
5. Molecular profiles of HCV cirrhotic tissues derived in a panel of markers with clinical utility for hepatocellular carcinoma surveillance.
Gehrau RC; Archer KJ; Mas VR; Maluf DG
PLoS One; 2012; 7(7):e40275. PubMed ID: 22792259
[TBL] [Abstract][Full Text] [Related]
6. Molecular signatures associated with HCV-induced hepatocellular carcinoma and liver metastasis.
De Giorgi V; Buonaguro L; Worschech A; Tornesello ML; Izzo F; Marincola FM; Wang E; Buonaguro FM
PLoS One; 2013; 8(2):e56153. PubMed ID: 23441164
[TBL] [Abstract][Full Text] [Related]
7. Study of some potential biomarkers in Egyptian hepatitis C virus patients in relation to liver disease progression and HCC.
Baraka K; Abozahra RR; Badr E; Abdelhamid SM
BMC Cancer; 2023 Oct; 23(1):938. PubMed ID: 37798688
[TBL] [Abstract][Full Text] [Related]
8. How do persistent infections with hepatitis C virus cause liver cancer?
Mitchell JK; Lemon SM; McGivern DR
Curr Opin Virol; 2015 Oct; 14():101-8. PubMed ID: 26426687
[TBL] [Abstract][Full Text] [Related]
9. Artificial intelligence-based prediction of molecular and genetic markers for hepatitis C-related hepatocellular carcinoma.
Colak C; Kucukakcali Z; Akbulut S
Ann Med Surg (Lond); 2023 Oct; 85(10):4674-4682. PubMed ID: 37811067
[TBL] [Abstract][Full Text] [Related]
10. Telomerase Expression Related with Poor Immune Response to HCV Core Antigen in Egyptian HCV Patients' PBMCs.
Ibrahim IH; Ali OSM; El-Sahar AA; Elrefaei M; El-Sheikh N
J Clin Exp Hepatol; 2023; 13(6):1008-1016. PubMed ID: 37975051
[TBL] [Abstract][Full Text] [Related]
11. A rapid and stable spontaneous reprogramming system of Spermatogonial stem cells to Pluripotent State.
Wei R; Zhang X; Li X; Wen J; Liu H; Fu J; Li L; Zhang W; Liu Z; Yang Y; Zou K
Cell Biosci; 2023 Dec; 13(1):222. PubMed ID: 38041111
[TBL] [Abstract][Full Text] [Related]
12. Mycobiota and C-Type Lectin Receptors in Cancers: Know thy Neighbors.
Zhang L; Chai D; Chen C; Li C; Qiu Z; Kuang T; Parveena M; Dong K; Yu J; Deng W; Wang W
Front Microbiol; 2022; 13():946995. PubMed ID: 35910636
[TBL] [Abstract][Full Text] [Related]
13. CARD9 Signaling, Inflammation, and Diseases.
Liu X; Jiang B; Hao H; Liu Z
Front Immunol; 2022; 13():880879. PubMed ID: 35432375
[TBL] [Abstract][Full Text] [Related]
14. Abdominal ultrasound and alpha-foetoprotein for the diagnosis of hepatocellular carcinoma in adults with chronic liver disease.
Colli A; Nadarevic T; Miletic D; Giljaca V; Fraquelli M; Štimac D; Casazza G
Cochrane Database Syst Rev; 2021 Apr; 4(4):CD013346. PubMed ID: 33855699
[TBL] [Abstract][Full Text] [Related]
15. Caspase recruitment domain family member 9 expression is a promising biomarker in esophageal squamous cell carcinoma.
Sekino N; Kano M; Sakata H; Murakami K; Toyozumi T; Matsumoto Y; Ryuzaki T; Ikeda J; Ota M; Matsubara H
Ann Gastroenterol Surg; 2020 Mar; 4(2):135-141. PubMed ID: 32258978
[TBL] [Abstract][Full Text] [Related]
16. Transcriptomic analysis and mutational status of IDH1 in paired primary-recurrent intrahepatic cholangiocarcinoma.
Peraldo-Neia C; Ostano P; Cavalloni G; Pignochino Y; Sangiolo D; De Cecco L; Marchesi E; Ribero D; Scarpa A; De Rose AM; Giuliani A; Calise F; Raggi C; Invernizzi P; Aglietta M; Chiorino G; Leone F
BMC Genomics; 2018 Jun; 19(1):440. PubMed ID: 29871612
[TBL] [Abstract][Full Text] [Related]
17. Caspase recruitment domains. New potential markers for diagnosis of hepatocellular carcinoma associated with HCV in Egyptian patients.
Zekri AR; El-Kassas M; Saad Y; Bahnassy A; El-Din HK; Darweesh SK; Abdel Hafez H; Esmat G
Ann Hepatol; 2013; 12(5):774-81. PubMed ID: 24018495
[TBL] [Abstract][Full Text] [Related]
18. Serum Beta-2 Microglobulin: a Possible Marker for Disease Progression in Egyptian Patients with Chronic HCV Related Liver Diseases.
Ouda SM; Khairy AM; Sorour AE; Mikhail MN
Asian Pac J Cancer Prev; 2015; 16(17):7825-9. PubMed ID: 26625805
[TBL] [Abstract][Full Text] [Related]
19. Des-gamma-carboxyprothrombin, alpha-fetoprotein and AFP-L3 in patients with chronic hepatitis, cirrhosis and hepatocellular carcinoma.
Durazo FA; Blatt LM; Corey WG; Lin JH; Han S; Saab S; Busuttil RW; Tong MJ
J Gastroenterol Hepatol; 2008 Oct; 23(10):1541-8. PubMed ID: 18422961
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
